Pulmonary static inflation with 50% xenon attenuates decline in tissue factor in patients undergoing Stanford type A acute aortic dissection repair

The Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively and require blood products and transfusions. Thus, we studied how xenon alters coagulation using thromboelastography (TEG) and conventional he...

Full description

Saved in:
Bibliographic Details
Published inJournal of thoracic disease Vol. 10; no. 7; pp. 4368 - 4376
Main Authors Pan, Xudong, Lu, Jiakai, Cheng, Weiping, Yang, Yanwei, Zhu, Junming, Jin, Mu
Format Journal Article
LanguageEnglish
Published China AME Publishing Company 01.07.2018
Subjects
Online AccessGet full text
ISSN2072-1439
2077-6624
DOI10.21037/jtd.2018.06.95

Cover

Abstract The Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively and require blood products and transfusions. Thus, we studied how xenon alters coagulation using thromboelastography (TEG) and conventional hemostatic tests for patients with AAD undergoing aortic arch surgery involving cardiopulmonary bypass (CPB)/deep hypothermic circulatory arrest (DHCA). This prospective single-center nonrandomized controlled clinical trial, registered in the Chinese Clinical Trial Registry (ChiCTR-ICR-15006435), assessed perioperative clinical variables and serological results from 50 subjects undergoing pulmonary static inflation with 50% nitrogen/50% oxygen from January 2013 to January 2014 and 50 subjects undergoing pulmonary static inflation with 50% xenon/50% oxygen from January 2014 to December 2014 during CPB for Stanford type A AAD. Repeated measures ANOVA were used to identify the effects of xenon on coagulation after surgery. The primary endpoint was perioperative changes in coagulation and fibrinolysis after intubation and 10 minutes, and 6 hours after the operation. The secondary endpoint was to assess the perioperative changes in serum level of tissue factor (TF), tissue factor pathway inhibitor (TFPI) and tissue plasminogen activator (tPA) after intubation and 10 minutes, and 6 hours after the operation. Mean prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), median fibrinogen degradation product (FDP), and D-dimer peaked and then decreased over 6 hours after surgery. TEG followed a similar trend. From the start to the end of surgery and until 6 h after surgery, mean TF decreased in controls (β -2.61, P<0.001 and β -2.83, P<0.001, respectively), but was maintained relatively stable in xenon group (β -0.5, P<0.001 and β -0.96, P<0.001, respectively). Deterioration of coagulation function and activated fibrinolysis was confirmed by conventional tests and TEG analysis after Stanford type A AAD repair. Pulmonary static inflation with 50% xenon attenuates decline in TF in patients undergoing Stanford type A AAD repair.
AbstractList The Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively and require blood products and transfusions. Thus, we studied how xenon alters coagulation using thromboelastography (TEG) and conventional hemostatic tests for patients with AAD undergoing aortic arch surgery involving cardiopulmonary bypass (CPB)/deep hypothermic circulatory arrest (DHCA).BACKGROUNDThe Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively and require blood products and transfusions. Thus, we studied how xenon alters coagulation using thromboelastography (TEG) and conventional hemostatic tests for patients with AAD undergoing aortic arch surgery involving cardiopulmonary bypass (CPB)/deep hypothermic circulatory arrest (DHCA).This prospective single-center nonrandomized controlled clinical trial, registered in the Chinese Clinical Trial Registry (ChiCTR-ICR-15006435), assessed perioperative clinical variables and serological results from 50 subjects undergoing pulmonary static inflation with 50% nitrogen/50% oxygen from January 2013 to January 2014 and 50 subjects undergoing pulmonary static inflation with 50% xenon/50% oxygen from January 2014 to December 2014 during CPB for Stanford type A AAD. Repeated measures ANOVA were used to identify the effects of xenon on coagulation after surgery. The primary endpoint was perioperative changes in coagulation and fibrinolysis after intubation and 10 minutes, and 6 hours after the operation. The secondary endpoint was to assess the perioperative changes in serum level of tissue factor (TF), tissue factor pathway inhibitor (TFPI) and tissue plasminogen activator (tPA) after intubation and 10 minutes, and 6 hours after the operation.METHODSThis prospective single-center nonrandomized controlled clinical trial, registered in the Chinese Clinical Trial Registry (ChiCTR-ICR-15006435), assessed perioperative clinical variables and serological results from 50 subjects undergoing pulmonary static inflation with 50% nitrogen/50% oxygen from January 2013 to January 2014 and 50 subjects undergoing pulmonary static inflation with 50% xenon/50% oxygen from January 2014 to December 2014 during CPB for Stanford type A AAD. Repeated measures ANOVA were used to identify the effects of xenon on coagulation after surgery. The primary endpoint was perioperative changes in coagulation and fibrinolysis after intubation and 10 minutes, and 6 hours after the operation. The secondary endpoint was to assess the perioperative changes in serum level of tissue factor (TF), tissue factor pathway inhibitor (TFPI) and tissue plasminogen activator (tPA) after intubation and 10 minutes, and 6 hours after the operation.Mean prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), median fibrinogen degradation product (FDP), and D-dimer peaked and then decreased over 6 hours after surgery. TEG followed a similar trend. From the start to the end of surgery and until 6 h after surgery, mean TF decreased in controls (β -2.61, P<0.001 and β -2.83, P<0.001, respectively), but was maintained relatively stable in xenon group (β -0.5, P<0.001 and β -0.96, P<0.001, respectively).RESULTSMean prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), median fibrinogen degradation product (FDP), and D-dimer peaked and then decreased over 6 hours after surgery. TEG followed a similar trend. From the start to the end of surgery and until 6 h after surgery, mean TF decreased in controls (β -2.61, P<0.001 and β -2.83, P<0.001, respectively), but was maintained relatively stable in xenon group (β -0.5, P<0.001 and β -0.96, P<0.001, respectively).Deterioration of coagulation function and activated fibrinolysis was confirmed by conventional tests and TEG analysis after Stanford type A AAD repair. Pulmonary static inflation with 50% xenon attenuates decline in TF in patients undergoing Stanford type A AAD repair.CONCLUSIONSDeterioration of coagulation function and activated fibrinolysis was confirmed by conventional tests and TEG analysis after Stanford type A AAD repair. Pulmonary static inflation with 50% xenon attenuates decline in TF in patients undergoing Stanford type A AAD repair.
The Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively and require blood products and transfusions. Thus, we studied how xenon alters coagulation using thromboelastography (TEG) and conventional hemostatic tests for patients with AAD undergoing aortic arch surgery involving cardiopulmonary bypass (CPB)/deep hypothermic circulatory arrest (DHCA). This prospective single-center nonrandomized controlled clinical trial, registered in the Chinese Clinical Trial Registry (ChiCTR-ICR-15006435), assessed perioperative clinical variables and serological results from 50 subjects undergoing pulmonary static inflation with 50% nitrogen/50% oxygen from January 2013 to January 2014 and 50 subjects undergoing pulmonary static inflation with 50% xenon/50% oxygen from January 2014 to December 2014 during CPB for Stanford type A AAD. Repeated measures ANOVA were used to identify the effects of xenon on coagulation after surgery. The primary endpoint was perioperative changes in coagulation and fibrinolysis after intubation and 10 minutes, and 6 hours after the operation. The secondary endpoint was to assess the perioperative changes in serum level of tissue factor (TF), tissue factor pathway inhibitor (TFPI) and tissue plasminogen activator (tPA) after intubation and 10 minutes, and 6 hours after the operation. Mean prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), median fibrinogen degradation product (FDP), and D-dimer peaked and then decreased over 6 hours after surgery. TEG followed a similar trend. From the start to the end of surgery and until 6 h after surgery, mean TF decreased in controls (β -2.61, P<0.001 and β -2.83, P<0.001, respectively), but was maintained relatively stable in xenon group (β -0.5, P<0.001 and β -0.96, P<0.001, respectively). Deterioration of coagulation function and activated fibrinolysis was confirmed by conventional tests and TEG analysis after Stanford type A AAD repair. Pulmonary static inflation with 50% xenon attenuates decline in TF in patients undergoing Stanford type A AAD repair.
Author Pan, Xudong
Cheng, Weiping
Yang, Yanwei
Lu, Jiakai
Zhu, Junming
Jin, Mu
Author_xml – sequence: 1
  givenname: Xudong
  surname: Pan
  fullname: Pan, Xudong
– sequence: 2
  givenname: Jiakai
  surname: Lu
  fullname: Lu, Jiakai
– sequence: 3
  givenname: Weiping
  surname: Cheng
  fullname: Cheng, Weiping
– sequence: 4
  givenname: Yanwei
  surname: Yang
  fullname: Yang, Yanwei
– sequence: 5
  givenname: Junming
  surname: Zhu
  fullname: Zhu, Junming
– sequence: 6
  givenname: Mu
  surname: Jin
  fullname: Jin, Mu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30174885$$D View this record in MEDLINE/PubMed
BookMark eNp1UUtLHTEUDsVS7a3r7iQboZu55jWPbASRvkBooboOmeTMNTI3GZOMrb-jf7iZq5VWMJsczvkeh_O9RXs-eEDoPSVrRglvT26yXTNCuzVp1rJ-hQ4YaduqaZjY29WsooLLfXSY0g0pryGMte0btM8JbUXX1Qfo9_d53Aav4z1OWWdnsPPDWIrg8U-Xr3FNjvEvKM5Y5wx-1hkStmBG56FgcXYpzYAHbXKIS2MqZPA54dlbiJvg_Ab_yNoPIVqc7yfAZ1ibOQPWIS6GtiiA2TlGmLSL79DrQY8JDh__Fbr69PHy_Et18e3z1_Ozi8pwyXMlNCHUMk2MYJoBY5JT6KytGyYHJqHvOymE0Y3oSl9I27ZsEB3nuofe1JSv0OmD7jT3W7CmbB31qKbotuUeKmin_p94d6024U41tJyyJLBCHx4FYridIWW1dcnAOGoPYU6KESmJoJws0KN_vZ5M_iZRACcPABNDShGGJwglahe3KnGrJW5FGiUXRv2MYVzeJVeWdeOLvD_QGbKk
CitedBy_id crossref_primary_10_3389_fcvm_2023_1109620
crossref_primary_10_1186_s13019_020_01383_w
crossref_primary_10_1186_s13019_020_01296_8
crossref_primary_10_1186_s13063_024_08290_8
ContentType Journal Article
Copyright 2018 Journal of Thoracic Disease. All rights reserved. 2018 Journal of Thoracic Disease.
Copyright_xml – notice: 2018 Journal of Thoracic Disease. All rights reserved. 2018 Journal of Thoracic Disease.
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.21037/jtd.2018.06.95
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2077-6624
EndPage 4376
ExternalDocumentID PMC6106010
30174885
10_21037_jtd_2018_06_95
Genre Journal Article
GroupedDBID 53G
AAKDD
AAWTL
AAYXX
ACGFO
ADBBV
AENEX
AIAGR
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BMSDO
CITATION
DIK
GX1
HYE
OK1
RPM
04C
M~E
NPM
7X8
5PM
ID FETCH-LOGICAL-c393t-4a001d2a0c42a2e22931e8dd5629f29ebb8944ca6481e849d772f4833abebc513
ISSN 2072-1439
IngestDate Thu Aug 21 14:14:08 EDT 2025
Thu Sep 04 23:02:35 EDT 2025
Wed Feb 19 02:43:29 EST 2025
Tue Jul 01 04:37:33 EDT 2025
Thu Apr 24 22:58:41 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords blood coagulation disorders
Ruptured aortic aneurysm
xenon
tissue factor (TF)
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c393t-4a001d2a0c42a2e22931e8dd5629f29ebb8944ca6481e849d772f4833abebc513
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Contributions: (I) Conception and design: X Pan, J Lu, W Cheng, J Zhu, M Jin; (II) Administrative support: None; (III) Provision of study materials or patients: J Zhu, M Jin; (IV) Collection and assembly of data: X Pan, Y Yang; (V) Data analysis and interpretation: X Pan, J Lu, W Cheng, J Zhu, M Jin; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.
These authors contributed equally to this work.
OpenAccessLink https://jtd.amegroups.com/article/viewFile/22270/pdf
PMID 30174885
PQID 2099041300
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6106010
proquest_miscellaneous_2099041300
pubmed_primary_30174885
crossref_primary_10_21037_jtd_2018_06_95
crossref_citationtrail_10_21037_jtd_2018_06_95
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-7-00
2018-Jul
20180701
PublicationDateYYYYMMDD 2018-07-01
PublicationDate_xml – month: 07
  year: 2018
  text: 2018-7-00
PublicationDecade 2010
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Journal of thoracic disease
PublicationTitleAlternate J Thorac Dis
PublicationYear 2018
Publisher AME Publishing Company
Publisher_xml – name: AME Publishing Company
SSID ssj0000602277
Score 2.1472454
Snippet The Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 4368
SubjectTerms Original
Title Pulmonary static inflation with 50% xenon attenuates decline in tissue factor in patients undergoing Stanford type A acute aortic dissection repair
URI https://www.ncbi.nlm.nih.gov/pubmed/30174885
https://www.proquest.com/docview/2099041300
https://pubmed.ncbi.nlm.nih.gov/PMC6106010
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA7jCuLL4t1ZL0RQEIaumfT-OIiyCCv7sIvjU0mTjFtdZmS2RfFv-If8aZ6T06ad0YHVl86QpunlfD3nS3oujD0HpV_aTC2C2KRRgMGP8EplIjBSWhVp2G0wwPn4fXJ0Fr2bx_PR6NfAa6mpy0P9469xJf8jVWgDuWKU7D9I1g8KDfAf5AtbkDBsryTjk-YCzoV-bxgXVGl0rSLfNlpfjcULGU--2yW6HNfAjhtklhNjtSOX6OLonntbdWfS51m9dPVx159WlLBbLV1YoVuvnU2URucCtcILmrgP-lRvfA2mrVrvoLv1OYBN0wHDT0IntAI7b8yqNaLoHtQ4dFXqi6p6BwRLeumDxXrbvu_HdsUbfr_ZariKMc28x2ur7KRIZQDcjdSn7drSIEkoxtprazFAZTpQvZhKf2DGo5DqymybCNlmGfhcY57YqcveSmU-N5NxbxlJ77oIkyY3RAEDFDhAIZIij6-x6zJNnaNAt15EXABTNGLMvr9Byi_lxni1eRGb1OiP-c622-6AB53eYvutRPmM0HibjezyDrtx3Lpo3GU_PSg5gZJ7UHIEJQdQcgdJ3kOSt5CEvpwgyQmS2NBBkveQ5B0kOUKSz7iDJCdI8h6SnCB5j529fXP6-ihoK38EOszDOogUsCcjlQBloaSVwEmnNjMGyHq-kLktyyyPIq2SKIP2KDcwR1xEWRiq0pY6nob32R7ch33IeCoMMPRFbEus_JCaTJRayVDHCxHHMgnH7LB76IVu0-JjdZaLYoekx-ylP-ArZYTZ3fVZJ8UCtDZ-ilNLu2ouCwxYF8gfxZg9IKn6wcDkpmBW4eh0Q96-A2aE39yzrM5dZniYC-ECy8HVL_ERu9m_jo_ZXr1u7BOg2XX51CH5N_nz2Dk
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pulmonary+static+inflation+with+50%25+xenon+attenuates+decline+in+tissue+factor+in+patients+undergoing+Stanford+type+A+acute+aortic+dissection+repair&rft.jtitle=Journal+of+thoracic+disease&rft.au=Pan%2C+Xudong&rft.au=Lu%2C+Jiakai&rft.au=Cheng%2C+Weiping&rft.au=Yang%2C+Yanwei&rft.date=2018-07-01&rft.issn=2072-1439&rft.eissn=2077-6624&rft.volume=10&rft.issue=7&rft.spage=4368&rft.epage=4376&rft_id=info:doi/10.21037%2Fjtd.2018.06.95&rft.externalDBID=n%2Fa&rft.externalDocID=10_21037_jtd_2018_06_95
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-1439&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-1439&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-1439&client=summon